$300 Million Health Care Finance Acquisition
Represented a company in the health care finance industry acquired in a $300 million transaction.
Successful Outcome for Medical Professional in Connection with Federal False Claims Act Investigation
Defense and non-trial resolution for a medical professional in response to a civil investigative demand issued in connection with a federal False Claims Act investigation.
Favorable Pre-lawsuit Settlement in Federal False Claims Act Case for Cardiologist
Effectuated a favorable pre-lawsuit settlement with no admission of liability in a federal False Claims Act matter on behalf of a cardiologist in the Philadelphia region.
$1.3 Billion Sale of Health Care Provider
Served as lead counsel in $1.3 billion sale of health care provider to a strategic buyer.
$114 Million Common Stock Offering for Wholesale Pharma Distributor
Represented a wholesale pharmaceutical distributor as issuer’s counsel in a $114 million underwritten offering of common stock.
Provided Counsel to Pharma Company in Connection with Policies and Procedures
Assisted a major pharmaceutical company with a comprehensive update of policies, including on issues such as interactions with healthcare providers, sponsorships, educational grants, exhibits and charitable donations, to ensure compliance with federal regulations and industry practice.
Favorable Resolution of Criminal Investigation for Senior Executive of Medical Device Manufacturer
Represented a senior executive at a medical device manufacturer in connection with a criminal investigation involving potential false statements to the U.S. Food and Drug Administration. Resolved without any criminal charges.
Defended Health Care Network from Employment Disability Discrimination Claim
Successfully defended network of assisted living and long-term care facilities from employment disability discrimination claim filed with the Colorado Civil Rights Division and the U.S. Equal Employment Opportunity Commission, resulting in favorable settlement for client and resolution of all claims.
$95 Million Sale of Health Care Financing Company
Counsel to seller for the sale of health care financing company with an enterprise value of approximately $95 million. Sale was to a private-equity backed purchaser and involved a post-closing transition period for state licensing issues.
Structured Multimillion-Dollar, Multi-Year Sponsored Research Program and Joint Venture for Health Care Client
Structured a multimillion-dollar, multi-year sponsored research program and related joint venture, between a health care client and a leading research university. Structured budgeting and oversight mechanisms for research funding; structured LLC joint venture (JV) entity and related governance matters; completed licensing agreements and conducted analysis related to JV intellectual property ownership; all enabling future commercialization of intellectual property developed from funded research.
Secured Motion to Dismiss for Hospital in Protected Health Information, Termination Case
Prevailed on a contested Motion to Dismiss in favor of hospital client. Plaintiff alleged employment termination in part, due to our client’s allegedly inappropriate and unauthorized disclosure of protected health information. Plaintiff asserted a claim alleging breach of fiduciary duty of confidentiality, seeking both economic losses and punitive damages. Relying in part on HIPAA regulations, we filed a Motion to Dismiss and a Motion to Strike the punitive damages claims, and after oral argument, the Judge granted the Motion.
$300 Million Medical Device Industry Acquisition
Represented a public company in the medical device industry acquired in a $300 million transaction.
Selected to Assist OIG DHS as Directed by IL Governor in Investigation of Veterans' Home
Selected to assist the Office of the Inspector General for the Department of Human Services (OIG DHS), as directed by Illinois Gov. J.B. Pritzker, in conducting an investigation into the Fall 2020 COVID-19 outbreak at the LaSalle Veterans’ Home in LaSalle, Illinois, and in preparing a summary report. To ensure the investigation considered all relevant information, the investigative team spoke with Home personnel, including management and front line staff. In addition, the investigative team interviewed officials with the Illinois Department of Veterans' Affairs, the Illinois Department of Public Health, and the U.S. Department of Veterans Affairs, and reviewed hundreds of documents.
$1.8 Billion Sale of Public Health Care Company
Represented a publicly listed home health care provider in the sale of their business. The transaction was valued at $1.8 billion, including the assumption of net debt.
$500 Million Acquisition of Global Business Unit
Served as counsel in the $500 million acquisition of a business unit of a global corporation focused in health care, research and diagnostics, by a global technology industry leader.
Counsel to Private Equity and Venture Capital Funds Across Industries
Counsel to venture capital funds and private equity funds, notably in the blockchain and distributed ledger technology, health care, transportation/logistics, energy, telecommunications, manufacturing, consumer products, and building products industries.
Delaware Counsel in Specialty Pharma Company Bankruptcy
Delaware counsel to the Official Committee of Unsecured Creditors in the bankruptcy cases for a specialty pharmaceutical company.
Represented Medical Technology Company in IPO
Supported a medical technology company in completing its Initial Public Offering and trading on the Nasdaq.
Worldwide Freezing Injunction Against Parties Suspected of Commercial Fraud
Assisted a client in the pharmaceutical industry with an urgent application for injunctive relief in connection with the supply of PPE. The high-value dispute involved complex contractual issues and investigations into suspected fraud and misconduct.
Defending a Cross-Continental Claim Brought Against a Pharmaceutical Company
Assisted a client in the pharmaceutical industry in defending a multimillion-pound contractual claim brought against it. The high-value dispute included complex multi-jurisdictional issues concerning security for costs and e-discovery.
Successful Settlement in $400 Million Qui Tam Case
Successfully negotiated a no admission of liability settlement on behalf of a pharmaceutical company in connection with a civil False Claims Act matter investigated by the U.S. Attorney’s Office for the Eastern District of Pennsylvania. The case originated from a qui tam complaint where the government initially sought damages well in excess of $400 million. The case was resolved for approximately 4% of the initial damages assessment, and a Corporate Integrity Agreement was reached with Department of Health and Human Services Office of Inspector General (HHSOIG) that avoided any debarment or exclusion sanctions.
Successful Defense of Medical Practice in FCA Litigation
Successful defense of a medical practice in a federal civil False Claims Act litigation involving a qui tam relator.
Obtained Declination of Prosecution from DOJ for Prominent Medical Doctor
Obtained a declination of prosecution from the Department of Justice on behalf of a prominent medical doctor practicing in the Philadelphia region accused of billing fraud.
Advised German Pharma Company on Immigration Obligations Following Acquisition
Advised a Germany-based pharmaceutical company in their immigration obligations following the acquisition of an Oxford-based laboratory and its workforce.
Outside Counsel for $8.5 Billion Life Sciences Company
As outside counsel for an $8.5 billion life sciences company, led a team managing all aspects of IP strategy and execution for a $20 million annual R&D function. Represented the company in multiple M&A transactions over $200 million and advised senior leadership on major strategic decisions around new product launches, commercial partnerships and licenses.
Led Defense Strategy Resulting in Defense Verdict in High-Profile Antitrust Class Action
Represented major, multinational biopharmaceutical company in a massive, high-profile antitrust class action lawsuit in which plaintiffs were seeking in excess of $30 billion in damages. As Global Head of Litigation, led legal defense strategy resulting in a jury defense verdict.
Representation of Health Care Facilities in Various Breaches, Related Lawsuits Involving HIPAA
Represented health care facilities in data breaches, lawsuits and investigations involving the Health Insurance Portability and Accountability Act (HIPAA).
Advised Overseas Pharma Company in Defense of High Court Proceedings
Advised a leading overseas pharma company in its defense of significant High Court proceedings.
Advised U.K. Pharma Company in Defamatory Reporting Case
Advised a U.K. pharmaceutical company concerning defamatory reporting in the media about one of its key products.
Sake of Life Science Intermediary
Advised the shareholders of the largest provider of IVF programmes in the U.K. on their sale to a private equity buyer.
- Page 1 of 3